Clinical efficacy and safety of platinum-containing neoadjuvant immunotherapy for triple-negative breast cancer

Clinical efficacy and safety of platinum-containing neoadjuvant immunotherapy for triple-negative breast cancer

Objective To evaluate the clinical efficacy and safety of platinum-containing neoadjuvant immunotherapy for triple-negative breast cancer. Methods Sixty-four patients with PD-L1 positive triple-negative breast cancer were enrolled and randomly divided into the control（<i>n = </i>32）and o...

Full description

Bibliographic Details
Main Author:	Yin Yulai, Zhang Yinxu, Ren Yue, Zhang Hui, Zhang Xiaoyu
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of New Medicine 2024-01-01
Series:	Xin yixue
Subjects:	triple-negative breast cancer\|programmed death receptor-1 inhibitor\|neoadjuvant immunotherapy\|breast-conserving surgery\|axillary lymph node dissection\|pathologic complete response
Online Access:	https://www.xinyixue.cn/fileup/0253-9802/PDF/1708410527639-1577738288.pdf

Similar Items

Higher Pathological Complete Response Rate of Less than 10 Total Axillary Lymph Nodes After Axillary Lymph Node Dissection Following Neoadjuvant Chemotherapy in Breast Cancer
by: Jeeyeon Lee, et al.
Published: (2022-03-01)

Factors Affecting the Complete Response in Breast and Axillary Regions Following Neoadjuvant Chemotherapy for Breast Cancer
by: Halit Ozgul, et al.
Published: (2024-09-01)

The analysis of axillary lymph nodes metastasis after neoadjuvant therapy in breast cancer
by: BI Zhao, CHEN Peng, QIU Pengfei, CHEN Yuguang, WANG Yongsheng
Published: (2023-04-01)

Factors influencing the accuracy of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer
by: YUAN Jie*, ZHANG Hua, WANG Qun, WANG Bei, HUANG Jun, YANG Li, WANG Minghua
Published: (2023-11-01)

Questions of axillary region surgery in breast cancer patients after systemic neoadjuvant therapy
by: A. A. Bozhok, et al.
Published: (2022-01-01)

Biopsie du ganglion sentinelle après chimiothérapie néoadjuvante dans le cancer du sein [Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer]
by: Khadidja Brahmi, et al.
Published: (2024-08-01)

Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy
by: Mahmut Muslumanoglu, et al.
Published: (2024-10-01)

The Adventure of Axillary Treatment in Early Stage Breast Cancer
by: Bekir Kuru
Published: (2020-01-01)

COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER
by: P. V. Krivorotko, et al.
Published: (2017-12-01)

Research progress of axillary de-escalation management after neoadjuvant chemotherapy for clinical lymph node positive patients
by: FAN Qingda, CONG Binbin, CHEN Yuguang, DUAN Baowei, WANG Yongsheng
Published: (2023-02-01)

Prediction of axillary lymph node pathological complete response to neoadjuvant therapy using nomogram and machine learning methods
by: Tianyang Zhou, et al.
Published: (2022-10-01)

A delta-radiomic lymph node model using dynamic contrast enhanced MRI for the early prediction of axillary response after neoadjuvant chemotherapy in breast cancer patients
by: Shasha Liu, et al.
Published: (2023-01-01)

Tumor Characteristics Associated with Axillary Nodal Positivity in Triple Negative Breast Cancer
by: Neha Chintapally, et al.
Published: (2023-09-01)

Analysis of the Clinical Molecular Characteristics and Neoadjuvant Chemotherapy Response in Patients with Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer and Axillary Lymph Node Metastasis
by: Jin-Ping Ma, et al.
Published: (2022-06-01)

A study of neutrophil to lymphocyte ratio for the prediction of axillary pathological complete response after neoadjuvant therapy in breast cancer
by: BI Zhao , SONG Xianrang , CHEN Peng , XIE Li , JIANG Wei , SONG Xingguo , CONG Binbin , WANG Yongsheng
Published: (2021-01-01)

Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial)
by: Amparo Garcia-Tejedor, et al.
Published: (2023-08-01)

Intensive treatment of triple negative breast cancer with residual positive axillary lymph node after neoadjuvant chemotherapy
by: Xing Wang, et al.
Published: (2024-11-01)

Early-stage triple negative breast cancer: the therapeutic role of immunotherapy and the prognostic value of pathological complete response
by: Pierluigi De Santis, et al.
Published: (2024-02-01)

Necessity of Low Partial Axillary Lymph Node Dissection for Breast Cancer Patients with Negative Result of Sentinel Lymph Node Biopsy
by: LIU Xuan, et al.
Published: (2018-12-01)

Oncologic Outcomes with Neoadjuvant Chemotherapy and Breast Conservation for MRI Occult Breast Cancer
by: Brady Scott Laughlin, et al.
Published: (2018-08-01)

Sentinel node biopsy in breast cancer: results in a large series
by: S.M.T. Carvalho, et al.
Published: (2010-06-01)

Micrometastases in axillary lymph nodes in breast cancer, post-neoadjuvant systemic therapy
by: Janghee Lee, et al.
Published: (2024-07-01)

Feasibility and accuracy of targeted axillary dissection in breast cancer patients; single center experience
by: Cemal Kaya, et al.
Published: (2024-01-01)

The use of longitudinal CT-based radiomics and clinicopathological features predicts the pathological complete response of metastasized axillary lymph nodes in breast cancer
by: Jia Wang, et al.
Published: (2024-05-01)

Initial results of a novel technique of clipped node localization in breast cancer patients postneoadjuvant chemotherapy: Skin Mark clipped Axillary nodes Removal Technique (SMART trial)
by: Geok Hoon Lim, et al.
Published: (2020-03-01)

Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment
by: da Silva JL, et al.
Published: (2021-01-01)

Platinum is essential in neoadjuvant treatment of triple-negative breast cancer: a network meta-analysis
by: Junjie Li, et al.
Published: (2022-05-01)

Axillary management in patients with clinical node-negative early breast cancer and positive sentinel lymph node: a systematic review and meta-analysis
by: Changzai Li, et al.
Published: (2024-01-01)

Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer
by: Khadidja Brahmi, et al.
Published: (2017-06-01)

Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
by: Paul Gass, et al.
Published: (2018-10-01)

Incorporating Lymphovenous Anastomosis in Clinically Node-Positive Women Receiving Neoadjuvant Chemotherapy: A Shared Decision-Making Model and Nuanced Approached to the Axilla
by: Daniel Ben Lustig, et al.
Published: (2023-04-01)

The effect of neoadjuvant chemotherapy on ductal carcinoma in situ in triple-negative breast cancer patients: A nationwide analysis
by: Eva L. Claassens, et al.
Published: (2025-04-01)

Predictive Factors and Prognostic Value of Pathologic Complete Response of Internal Mammary Lymph Nodes in Breast Cancer After Neoadjuvant Chemotherapy
by: ZHANG Weifang, et al.
Published: (2022-12-01)

Axillary ultrasound for predicting response to neoadjuvant treatment in breast cancer patients—a single institution experience
by: Nina Pislar, et al.
Published: (2023-09-01)

Assessment and Management of Axillary Lymph Nodes for Breast Cancer Under Concept of Precision Therapy
by: WANG Yu, et al.
Published: (2022-10-01)

Non-invasive prediction of axillary lymph node dissection exemption in breast cancer patients post-neoadjuvant therapy: A radiomics and deep learning analysis on longitudinal DCE-MRI data
by: Yushuai Yu, et al.
Published: (2024-10-01)

Pretreatment Sarcopenia and MRI-Based Radiomics to Predict the Response of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
by: Jiamin Guo, et al.
Published: (2024-06-01)

Assessing the Efficacy of Radioactive Iodine Seed Localisation in Targeted Axillary Dissection for Node-Positive Early Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy: A Systematic Review and Pooled Analysis
by: Munaser Alamoodi, et al.
Published: (2024-06-01)

Tailored axillary surgery – A novel concept for clinically node positive breast cancer
by: Martin Heidinger, et al.
Published: (2023-06-01)

Risk Factors Associated With Sentinel Lymph Node Metastasis in Clinically Node-Negative Breast Cancer
by: Hussain Adnan Abdulla, et al.
Published: (2023-07-01)